| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | No adverse event | FAERS: 66 | US FAERS | |
| 2 | Urticaria | FAERS: 47 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Hypersensitivity | FAERS: 23 | US FAERS | |
| 4 | Swelling | FAERS: 19 | US FAERS | |
| 5 | Pruritus | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 6 | Nausea | FAERS: 7 | US FAERS | |
| 7 | Vomiting | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Erythema | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Injection site pain | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 10 | Burning sensation | FAERS: 3 | US FAERS | |
| 11 | Infusion site irritation | FAERS: 3 | US FAERS | |
| 12 | Agranulocytosis | FAERS: 2 | US FAERS | |
| 13 | Alopecia | FAERS: 2 | US FAERS | |
| 14 | Cardiac Arrest | FAERS: 2 | US FAERS | |
| 15 | Dysgeusia | FAERS: 2 | US FAERS | |
| 16 | Panniculitis | FAERS: 2 | US FAERS | |
| 17 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 18 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 19 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 20 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 21 | Cyanosis | FAERS: 1 | US FAERS | |
| 22 | Diabetes Mellitus | FAERS: 1 | US FAERS | |
| 23 | Discomfort | FAERS: 1 | US FAERS | |
| 24 | Dizziness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Drug dose omission | FAERS: 1 | US FAERS | |
| 26 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 27 | Dysuria | FAERS: 1 | US FAERS | |
| 28 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 29 | Formication | FAERS: 1 | US FAERS | |
| 30 | Headache | FAERS: 1 | US FAERS | |
| 31 | Infusion Site Extravasation | FAERS: 1 | US FAERS | |
| 32 | Infusion site pain | FAERS: 1 | US FAERS | |
| 33 | Injection site indentation | FAERS: 1 | US FAERS | |
| 34 | Injection site irritation | FAERS: 1 | US FAERS | |
| 35 | Malaise | FAERS: 1 | US FAERS | |
| 36 | Monoplegia | FAERS: 1 | US FAERS | |
| 37 | Myopericarditis | FAERS: 1 | US FAERS | |
| 38 | Nervousness | FAERS: 1 | US FAERS | |
| 39 | Pain | FAERS: 1 | US FAERS | |
| 40 | Palpitations | FAERS: 1 | US FAERS | |
| 41 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 42 | Rash erythematous | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 43 | Seizure like phenomena | FAERS: 1 | US FAERS | |
| 44 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 45 | Syncope | FAERS: 1 | US FAERS | |
| 46 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 47 | Ventricular Fibrillation | FAERS: 1 | US FAERS | |
| 48 | Visual Impairment | FAERS: 1 | US FAERS | |
| 49 | Anaphylactoid Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 50 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 51 | Lymphadenopathy | Canada Vigilance: 1 | Canada Vigilance | |
| 52 | Pallor | Canada Vigilance: 2 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.